^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    R289

    i
    Associations
    News
    Trials
    Company:
    Rigel
    Drug class:
    IRAK-4 inhibitor, IRAK-1 inhibitor
    Related drugs:
    Associations
    News
    Trials